SK Chemical won the second trial over the Norvatis’s dementia patch treatment
As SK Chemical won the patent war over dementia patch treatment,its position has been significantly stable in the market
The Patent Court decided to take the side of the requesting company, SK Chemical, in the appellate trial of patent nullity related to the Norvatis’s dementia patch treatment ‘...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
